Afuco™ Anti-Human CD276 ADCC Therapeutic Antibody (MGA271), ADCC Enhanced
Anti-CD276 ADCC Enhanced Antibody (MGA271) is an ADCC enhanced antibody produced by our Afuco™ platform. MGA271 is a first-in-class, humanized IgG1κ monoclonal antibody that recognizes human B7-H3, a novel member of the B7 family of immune regulators. MGA271 has been Fc-engineered to further augment its tumor killing activity.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-112CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CD276 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |